Schang LM - Search Results

1

Histone H2A variant H2A.B is enriched in transcriptionally active HSV-1 lytic chromatin.

Flores E, Saddoris SM, Owens AK, Gibeault R, Depledge DP, Schang LM. Flores E, et al. Among authors: schang lm. bioRxiv [Preprint]. 2023 Dec 22:2023.12.22.573075. doi: 10.1101/2023.12.22.573075. bioRxiv. 2023. Update in: J Virol. 2024 Apr 16;98(4):e0201523. doi: 10.1128/jvi.02015-23 PMID: 38187672 Free PMC article. Updated. Preprint.

2

Transactivation of herpes simplex virus type 1 immediate-early gene expression by virion-associated factors is blocked by an inhibitor of cyclin-dependent protein kinases.

Jordan R, Schang L, Schaffer PA. Jordan R, et al. J Virol. 1999 Oct;73(10):8843-7. doi: 10.1128/JVI.73.10.8843-8847.1999. J Virol. 1999. PMID: 10482641 Free PMC article.

3

Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.

Schang LM, St Vincent MR, Lacasse JJ. Schang LM, et al. Antivir Chem Chemother. 2006;17(6):293-320. doi: 10.1177/095632020601700601. Antivir Chem Chemother. 2006. PMID: 17249245 Free article. Review.

4

Human PC4 is a substrate-specific inhibitor of RNA polymerase II phosphorylation.

Schang LM, Hwang GJ, Dynlacht BD, Speicher DW, Bantly A, Schaffer PA, Shilatifard A, Ge H, Shiekhattar R. Schang LM, et al. J Biol Chem. 2000 Mar 3;275(9):6071-4. doi: 10.1074/jbc.275.9.6071. J Biol Chem. 2000. PMID: 10692395 Free article.

5

Advances on cyclin-dependent kinases (CDKs) as novel targets for antiviral drugs.

Schang LM. Schang LM. Curr Drug Targets Infect Disord. 2005 Mar;5(1):29-37. doi: 10.2174/1568005053174609. Curr Drug Targets Infect Disord. 2005. PMID: 15777196 Review.

6

Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.

Schang LM, Phillips J, Schaffer PA. Schang LM, et al. J Virol. 1998 Jul;72(7):5626-37. doi: 10.1128/JVI.72.7.5626-5637.1998. J Virol. 1998. PMID: 9621021 Free PMC article.

7

Linker histones are mobilized during infection with herpes simplex virus type 1.

Conn KL, Hendzel MJ, Schang LM. Conn KL, et al. Among authors: schang lm. J Virol. 2008 Sep;82(17):8629-46. doi: 10.1128/JVI.00616-08. Epub 2008 Jun 25. J Virol. 2008. PMID: 18579611 Free PMC article.

8

The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression.

Schang LM, Hossain A, Jones C. Schang LM, et al. J Virol. 1996 Jun;70(6):3807-14. doi: 10.1128/JVI.70.6.3807-3814.1996. J Virol. 1996. PMID: 8648716 Free PMC article.

9

Activation of pro-survival CaMK4β/CREB and pro-death MST1 signaling at early and late times during a mouse model of prion disease.

Shott RH, Majer A, Frost KL, Booth SA, Schang LM. Shott RH, et al. Among authors: schang lm. Virol J. 2014 Sep 2;11:160. doi: 10.1186/1743-422X-11-160. Virol J. 2014. PMID: 25183307 Free PMC article.

10

A quantitative technique for the study of the latency of Aujeszky virus.

Schang LM, Osorio FA. Schang LM, et al. Rev Sci Tech. 1993 Jun;12(2):505-21. doi: 10.20506/rst.12.2.705. Rev Sci Tech. 1993. PMID: 8400390 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters